Magdalene K. Cook
Vorstandsvorsitzender bei Renovacor Holdings, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Thomas E. Needham | M | 60 |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | 5 Jahre |
| Joseph Carroll | M | - | 3 Jahre | |
| Mark Luellen | M | - |
University of Virginia
| - |
| John Casteen | M | 80 |
University of Virginia
| 34 Jahre |
| Arthur Michael Feldman | M | - |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | - |
| Jonas Grossman | M | 50 | 3 Jahre | |
| Thomas Litton | M | - |
University of Virginia
| - |
| Gregory Covino | M | 59 | 3 Jahre | |
| Joan Lau | M | 53 | 3 Jahre | |
| Gbola Amusa | M | 50 | 3 Jahre | |
| Timothy M. Laseter | M | - |
University of Virginia
| - |
| Kirby Lee Cramer | M | 87 |
University of Virginia
| - |
| Kenneth G. Elzinga | M | - |
University of Virginia
| 57 Jahre |
| Matthew Killeen | M | 42 | 3 Jahre | |
| Russell Greiff | M | - |
University of Virginia
| 5 Jahre |
| John Wynne | M | - |
University of Virginia
| - |
| Harry Harding | M | - |
University of Virginia
| 15 Jahre |
| Donald L. Dell | M | - |
University of Virginia
| - |
| Teresa A. Sullivan | F | - |
University of Virginia
| - |
| J. Hunter Downs | M | - |
University of Virginia
| - |
| Brett R. Blackman | M | 52 |
University of Virginia
| - |
| Brian R. Wamhoff | M | - |
University of Virginia
| - |
| Ghassan Shaker | M | 87 |
University of Virginia
| - |
| Robert H. Swindell | M | - |
University of Virginia
| - |
| Stuart S. Howards | M | - |
University of Virginia
| - |
| Kenneth Klotz | M | - |
University of Virginia
| - |
| Michael A. Coppola | M | - |
University of Virginia
| - |
| Kevin R. Lynch | M | - |
University of Virginia
| - |
| Sharon Presnell | M | 55 |
University of Virginia
| - |
| James H. Donovan | M | - |
University of Virginia
| - |
| Donald Brown | M | - |
University of Virginia
| - |
| Elizabeth White | M | - |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | 3 Jahre |
| Elizabeth Varon | F | - |
University of Virginia
| - |
| Archie Holmes | M | - |
University of Virginia
| - |
| Pamela Higgins | F | - |
University of Virginia
| - |
| Anthony de Bruyn | M | - |
University of Virginia
| - |
| Alfred Weaver | M | - |
University of Virginia
| - |
| Patricia Lampkin | F | - |
University of Virginia
| - |
| Chris Bierly | M | - |
University of Virginia
| - |
| Kumar Dhanasekharan | M | - | 3 Jahre | |
| Tyler Alexander | M | - |
University of Virginia
| - |
| Don E. Detmer | M | - |
University of Virginia
| - |
| Nandita Shangari | M | 43 |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | - |
| Robert Meyer | M | 65 |
University of Virginia
| - |
| Melody Barnes | F | 60 |
University of Virginia
| 6 Jahre |
| Ian Burbulis | M | - |
University of Virginia
| 11 Jahre |
| Linda Petrie | M | - |
University of Virginia
| - |
| Gretchen Tibbits | F | 56 |
University of Virginia
| - |
| Eric S. Nagy | M | - |
University of Virginia
| - |
| Scott B. Luftglass | M | - |
University of Virginia
| - |
| James Aylor | M | - |
University of Virginia
| - |
| Lawrence Becker | M | - |
University of Virginia
| - |
| Adam J. Katz | M | - |
University of Virginia
| - |
| Frank J. Rimkus | M | - |
University of Virginia
| - |
| C. Wilson McNeely | M | - |
University of Virginia
| 30 Jahre |
| Mark Paul Kritzman | M | - |
University of Virginia
| - |
| Bruce Bilger | M | 72 |
University of Virginia
| - |
| Philip B. Weymouth | M | - |
University of Virginia
| - |
| Mark Anderson | M | 48 |
University of Virginia
| - |
| John Strangfeld | M | 70 |
University of Virginia
| - |
| Douglas Scovanner | M | 68 |
University of Virginia
| - |
| William Powers | M | 83 |
University of Virginia
| - |
| James H. Wyckoff | M | 72 |
University of Virginia
| 16 Jahre |
| Byron F. Marchant | M | 66 |
University of Virginia
| - |
| Shiv Krishnan | M | - |
University of Virginia
| - |
| Sonja Perkins | F | 57 |
University of Virginia
| - |
| Landon Hilliard | M | 82 |
University of Virginia
| - |
| Kristiane Graham | F | 66 |
University of Virginia
| - |
| Carl P. Zeithaml | M | 74 |
University of Virginia
| 27 Jahre |
| Gary F. Holloway | M | 72 |
University of Virginia
| - |
| Edward Burton | M | 81 |
University of Virginia
| 36 Jahre |
| Barbara Jeremiah | F | 72 |
University of Virginia
| - |
| R. Helm Dobbins | M | 72 |
University of Virginia
| - |
| Steve P. Smiley | M | 75 |
University of Virginia
| - |
| David S. Gee | M | 69 |
University of Virginia
| - |
| Martina Hund-Mejean | F | 63 |
University of Virginia
| - |
| Robin A. Felder | M | - |
University of Virginia
| - |
| Barry W. Johnson | M | - |
University of Virginia
| - |
| Thomas J. Gampper | M | - |
University of Virginia
| - |
| Pete Kauffman | M | - |
University of Virginia
| - |
| Syaru Shirley Lin | M | 55 |
University of Virginia
| - |
| George T. Rodeheaver | M | - |
University of Virginia
| - |
| Michael Lincoln | M | - |
University of Virginia
| - |
| Isaac Manke | M | 47 |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | - |
| Thomas H. Estes | M | - |
University of Virginia
| - |
| Timothy B. Harris | M | - |
University of Virginia
| - |
| Carolyn S. Miles | F | 62 |
University of Virginia
| 15 Jahre |
| Neal F. Kassell | M | - |
University of Virginia
| - |
| Edward Benz | M | 78 |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | 7 Jahre |
| George Overstreet | M | - |
University of Virginia
| - |
| Elizabeth L. Anderson | M | 83 |
University of Virginia
| 19 Jahre |
| Randall W. Crenshaw | M | - |
University of Virginia
| - |
| Robert F. McNergney | M | - |
University of Virginia
| - |
| Timothy L. MacDonald | M | - |
University of Virginia
| - |
| Dennis S. Gertmenian | M | - |
University of Virginia
| - |
| David T. Perry | M | 59 |
University of Virginia
| - |
| Gordon F. Rainey | M | - |
University of Virginia
| - |
| Benjamin C. Ackerly | M | - |
University of Virginia
| 32 Jahre |
| Carol McNerney | F | - |
University of Virginia
| - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Fred Driscoll | M | 74 | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Magdalene K. Cook
- Persönliches Netzwerk
